Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 8, no: 0 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: Q9U1D7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 57 | 59 | PF00675 | 0.417 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.505 |
CLV_PCSK_KEX2_1 | 57 | 59 | PF00082 | 0.568 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 69 | 73 | PF00082 | 0.571 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.574 |
DOC_MAPK_MEF2A_6 | 104 | 112 | PF00069 | 0.487 |
DOC_USP7_MATH_1 | 40 | 44 | PF00917 | 0.517 |
DOC_USP7_UBL2_3 | 38 | 42 | PF12436 | 0.447 |
LIG_14-3-3_CanoR_1 | 152 | 156 | PF00244 | 0.490 |
LIG_14-3-3_CanoR_1 | 58 | 64 | PF00244 | 0.454 |
LIG_14-3-3_CanoR_1 | 80 | 88 | PF00244 | 0.491 |
LIG_BRCT_BRCA1_1 | 168 | 172 | PF00533 | 0.351 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.437 |
LIG_FHA_1 | 180 | 186 | PF00498 | 0.456 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.530 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.416 |
LIG_LIR_Apic_2 | 100 | 106 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 154 | 162 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 169 | 176 | PF02991 | 0.344 |
LIG_LIR_LC3C_4 | 6 | 9 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 154 | 158 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 169 | 175 | PF02991 | 0.272 |
LIG_SH2_CRK | 103 | 107 | PF00017 | 0.514 |
LIG_SH2_CRK | 155 | 159 | PF00017 | 0.462 |
LIG_SH2_CRK | 170 | 174 | PF00017 | 0.378 |
LIG_SH2_CRK | 60 | 64 | PF00017 | 0.385 |
LIG_SH2_SRC | 118 | 121 | PF00017 | 0.367 |
LIG_SH2_SRC | 124 | 127 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.544 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.537 |
LIG_SUMO_SIM_par_1 | 5 | 10 | PF11976 | 0.471 |
LIG_TYR_ITIM | 122 | 127 | PF00017 | 0.436 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.460 |
MOD_CK2_1 | 160 | 166 | PF00069 | 0.564 |
MOD_GlcNHglycan | 162 | 165 | PF01048 | 0.497 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.444 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.448 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.517 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.507 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.476 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.367 |
MOD_N-GLC_1 | 51 | 56 | PF02516 | 0.459 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.350 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.524 |
MOD_PIKK_1 | 87 | 93 | PF00454 | 0.568 |
MOD_PKA_2 | 140 | 146 | PF00069 | 0.459 |
MOD_PKA_2 | 151 | 157 | PF00069 | 0.492 |
MOD_PKB_1 | 97 | 105 | PF00069 | 0.438 |
MOD_Plk_1 | 22 | 28 | PF00069 | 0.607 |
MOD_Plk_2-3 | 22 | 28 | PF00069 | 0.607 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.565 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.369 |
MOD_SUMO_rev_2 | 74 | 82 | PF00179 | 0.460 |
TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.500 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.251 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.407 |
TRG_ER_diArg_1 | 57 | 59 | PF00400 | 0.428 |
TRG_Pf-PMV_PEXEL_1 | 174 | 178 | PF00026 | 0.433 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NRP9 | Trypanosomatidae | 39% | 99% |
A0A3Q8IFP0 | Leishmania donovani | 91% | 100% |
A0A422NZW7 | Trypanosoma rangeli | 39% | 99% |
A4HKU2 | Leishmania braziliensis | 78% | 99% |
A4I8C1 | Leishmania infantum | 91% | 100% |
D0AAJ3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 99% |
E9B380 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |